The directors of the California stem cell agency have adjourned their meeting in Berkeley. We do not expect additional stories today but will have more tomorrow including an update on the agency's search for a new home and an overview of the progress on CIRM 2.0. We call your attention to the item below that involves a flap over the agency's grant review process, which its president calls "sub-optimal."
(The progress report on CIRM 2.0 can be found here. The update on the search for a new CIRM home has been delayed.)
No comments:
Post a Comment